ReviewMolecular medicine reports2026
Advances in the biological functions of miR‑205 in various diseases (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs/miRs) are critical post‑transcriptional regulators of gene expression. Aberrant miRNA expression has been closely linked to the initiation and progression of a wide range of malignant and non‑malignant disorders, prompting extensive investigation into their biological functions, regulatory mechanisms and clinical relevance. Among these molecules, miR‑205 has attracted considerable attention owing to its unique expression patterns and context‑dependent roles. Notably, miR‑205 participates in epigenetic regulation, functions as either a tumor suppressor or oncogene, contributes to therapeutic resistance and exerts important effects on non‑cancerous diseases. The present review provides a comprehensive overview of the current understanding of miR‑205 in both malignant and non‑malignant conditions, highlights its major target genes and associated signaling pathways, and discusses its potential utility in the development of precise diagnostic, prognostic and therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.